The CP-ESP® disc prosthesis is intended to replace a damaged or diseased disc between two vertebrae of the cervical spine. The CP-ESP® disc prosthesis is designed to reproduce the natural behavior and physiological functions of a healthy disc.
Thanks to its viscoelastic PCU core, the CP-ESP® enable mimic natural motion in all six degrees of freedom (flexion-extension, lateral bending, translation, axial rotation and shock absorption or load bearing)
This flexible cushion, attached to the two metal endplates, provides the disc with its shock-absorbing function and limits the release of particles into the body and the calcification of deformable parts.
Indications
The CP-ESP® cervical disc prosthesis is designed for surgical treatment of degenerative disc disease (DDD) of the cervical spine in skeletally mature patients who have not responded after at least 6 months of conservative treatment. The assessment of the extent of disc involvement is based on the combination of data from the clinical examination and/or the symptoms and imaging.
The clinical examination and symptoms are defined by pain and/or a functional/neurological deficit in the neck or arm, with at least one of the following:
• Herniated disc
• Spondylarthrosis (defined by the presence of osteophytes)
• Radiculopathy
• Spinal cord compression.
The CP-ESP® cervical disc prosthesis is a medical device for primary treatment.
Features
- Benefits from over 10 years of development
- 6 degrees of freedom
- Adaptive center of rotation
- No surface bearing for increased lifetime
- Improvedstability
- Shock absorbing
- The CP-ESP® has spikes that ensure primary fixation to the vertebrae being treated.
- A hydroxyapatite coating over a rough, porous underlayer of T40 pure titanium allows for effective secondary fixation.
- Streamlined instrumentation
Product Range
- 3 heights (5, 6, 7mm)
- 3 footprints Size 1 (13×15), Size 2 (14×17) and size 3 (15×20)
- A total of 9 references
About Spineway Group
About Spineway
Spineway is an independent French company, founded in Lyon in 2005, and dedicated to the design and development of advanced technologies for spine surgery. Backed by 100% French know-how, we have contributed to more than 125,000 surgeries over the past 20 years. With the acquisitions of Distimp in 2021 and Spine Innovations in 2022, we have broadened our offering by combining complementary product portfolios and territories, while offering solutions to treat new pathologies.
Our CE0459 certified medical devices reflect our commitment to quality and safety. Spineway also holds 14 patent families in France and abroad, testifying to our commitment to innovation.
Spineway positions itself as much more than just a manufacturer, establishing close partnerships with surgeons. We offer an international program of customized training courses in surgical techniques, to meet the exact requirements and expectations of practitioner. Our 40 enthusiastic employees work side by side with you, listening to your expectations, to co-construct solutions adapted to a constantly evolving practice.
As a company on a human scale, we value the development of our teams, enabling them to give the best of themselves. Together, we are committed to improving the quality of care and advancing medicine.
About Spine Innovations
Spine Innovations is the manufacturer of the ESP disc protheses. The ESP disc prothesis is the result of 10 years of collaborative research work at the HôpitalPitié Salpêtrière in Paris, the French Atomic Energy Commission (CEA) and the UniversitéParis VI, and was driven by the Oséo Innovation contest in France.
Unlike traditional articulated prostheses composed of moving metal parts, ESP prostheses use a viscoelastic core designed to replicate the biomechanical behavior of a healthy intervertebral disc.
This technology is specifically designed to:
- preserve mobility in the operated segment;
- replicate the six physiological degrees of freedom;
- provide shock absorption similar to that of a natural disc.
The LP-ESP (lumbar prosthesis) received its CE marking in 2007and the CP-ESP® (cervical prosthesis) in 2012.
In 2020, Spine Innovation, an independent company, was founded to focus on the development, production, and marketing of ESP prostheses. In July 2022, Spineway acquired 100% of Spine Innovations as part of its external growth strategy.
About Distimp
From its inception in 2018, Distimp has focused on offering innovative solutions while drawing on a strong network of surgeons, particularly in France and Europe.
Spineway finalized the acquisition of 100% of Distimpin June 2021.
This transaction served several strategic objectives:
- to expand the group’s product portfolio;
- to strengthen its presence in the French market;
- to benefit from the network of surgeons developed by Distimp;
- to enhance its offering with new technical solutions for spinal surgery.